Plus produit pour Squamous Cell Carcinoma Antigen 1 ELISA Kit
Plus Kits ELISA pour Squamous Cell Carcinoma Antigen 1 partenaires d'interaction
Human Squamous Cell Carcinoma Antigen 1 (SCCA1) interaction partners
-
further showed a disease state mutant SPB3-Gly351Ala performed better anti-protease activity against FP2. This study, for the first time, has shown a serpin family inhibitor from human could efficiently inhibit activity of FP2.
-
this study shows that SERPINB4 contributes to survival of allergenic TH2 cells
-
SCCA2 is a reliable biomarker.
-
Fifty-two of 96 cases (54%) showed evaluated serum SCC antigen levels above the upper limit. The serum SCCA2 level was significantly higher in the head and neck SCC patients than in control group, whereas there were no significant differences in the serum SCCA1 level between head and neck SCC patients and control group.
-
Results provide evidence that SCCA1 overexpression is associated with poor prognosis in esophageal cancer patients. which is due to reduced tumor chemosensitivity as well as intratumoral immunity impairment, possibly mediated by the induction of the PD-L1 immune checkpoint regulator.
-
Concurrent elevation of preoperative SCC-Ag, CYFRA 21-1 and CRP serum levels can be correlated with worse survival rates in oral cavity squamous cell carcinoma.
-
While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing HCC in ALC
-
Results provide the first evidence that failure of serum SCCA to fall into the normal range by the fourth week of definitive radiotherapy is associated with significantly increased risk of recurrence and death.
-
The combination of SCCA-IgM with common clinical data shows promising diagnostic performance for the detection of Non-alcoholic steato-hepatitis in hepatitis C virus patients
-
Both periostin and SCCA may play a role in the pathogenesis of acute bronchitis due to respiratory syncytial virus
-
iron overload and was previously found capable of up-regulating SerpinB3 at the transcriptional level.
-
the SCCA-IgM determination could be helpful in predicting the response to therapy in patients with hepatocellular carcinoma.
-
Serum SCC-Ag, hs-CRP, and CA-125 were higher in recurrence cervical patients which could be potential biomarkers for predicting cervical cancer recurrence risk.
-
A close connection between SerpinB3 and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.
-
Findings point to potential interest of squamous cell carcinoma antigen SERPINB3/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.
-
Serum SCCA2 levels reflected disease severity and clinical type of atopic dermatitis. Serum SCCA2 may thus be a relevant biomarker for atopic dermatitis.
-
role of SERPINB3/B4 mutations in immunotherapy response
Squamous Cell Carcinoma Antigen 1 (SCCA1) profil antigène
Antigen Summary
May act as a protease inhibitor to modulate the host immune response against tumor cells.
Gene names and symbols associated with SCCA1
- serpin family B member 3 (SERPINB3) anticorps
- serpin family B member 4 (SERPINB4) anticorps
- HsT1196 anticorps
- LEUPIN anticorps
- PI11 anticorps
- SCC anticorps
- SCCA-1 anticorps
- SCCA-2 anticorps
- SCCA-PD anticorps
- SCCA1 anticorps
- SCCA2 anticorps
- T4-A anticorps
Protein level used designations for SCCA1
protein T4-A , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3 , serpin B3 , squamous cell carcinoma antigen 1 , PI-11 , SCCA2/SCCA1 fusion protein , peptidase inhibitor 11 , protease inhibitor (leucine-serpin) , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4 , serpin B4 , squamous cell carcinoma antigen 2
GENE ID | SPECIES |
---|---|
6317 | Homo sapiens |
6318 | Homo sapiens |
- Squalene Epoxidase Kits ELISA
- Spondin 2 Kits ELISA
- Spondin 1 Kits ELISA
- Split Hand/foot Malformation (Ectrodactyly) Type 1 Kits ELISA
- Splicing Regulatory Glutamine/lysine-Rich Protein 1 Kits ELISA
- Splicing Factor, Arginine/Serine Rich 7 Kits ELISA
- Splicing Factor 3b, Subunit 3, 130kDa Kits ELISA
- Splicing Factor 3b, Subunit 1, 155kDa Kits ELISA
- Splicing Factor 1 Kits ELISA
- Spleen tyrosine Kinase Kits ELISA
- Spleen Focus Forming Virus (SFFV) Proviral Integration Oncogene Spi1 Kits ELISA
- Spindlin 1 Kits ELISA
- Spindle and Kinetochore-Associated Protein 2 Kits ELISA
- Spi-C Transcription Factor (Spi-1/PU.1 Related) Kits ELISA
- SPHK1 Interactor, AKAP Domain Containing Kits ELISA
- Sphingosine-1-Phosphate Receptor 5 Kits ELISA
- Sphingosine-1-Phosphate Receptor 4 Kits ELISA
- Sphingosine-1-Phosphate Receptor 3 Kits ELISA
- Sphingosine-1-Phosphate Receptor 2 Kits ELISA
- Sphingosine-1-Phosphate Receptor 1 Kits ELISA
- Squamous Cell Carcinoma Antigen Recognized By T Cells Kits ELISA
- Squamous Cell Carcinoma Antigen Recognized By T Cells 3 Kits ELISA
- SR-Related CTD-Associated Factor 11 Kits ELISA
- SRC Kinase Signaling Inhibitor 1 Kits ELISA
- Src-Like-Adaptor Kits ELISA
- Src-Related Kinase Lacking C-Terminal Regulatory Tyrosine and N-Terminal Myristylation Sites Kits ELISA
- SRSF Protein Kinase 1 Kits ELISA
- SRY (Sex Determining Region Y)-Box 1 Kits ELISA
- SRY (Sex Determining Region Y)-Box 10 Kits ELISA
- SRY (Sex Determining Region Y)-Box 12 Kits ELISA
- SRY (Sex Determining Region Y)-Box 15 Kits ELISA
- SRY (Sex Determining Region Y)-Box 17 Kits ELISA
- SRY (Sex Determining Region Y)-Box 18 Kits ELISA
- SRY (Sex Determining Region Y)-Box 2 Kits ELISA
- SRY (Sex Determining Region Y)-Box 3 Kits ELISA
- SRY (Sex Determining Region Y)-Box 5 Kits ELISA
- SRY (Sex Determining Region Y)-Box 7 Kits ELISA
- SRY (Sex Determining Region Y)-Box 9 Kits ELISA
- SSB Kits ELISA
- ST3 beta-Galactoside alpha-2,3-Sialyltransferase 1 Kits ELISA